SevenOneSeven Capital Management’s Novavax NVAX Stock Holding History

SevenOneSeven Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,894	Closed	-$112K	–	59
2022 Q4	$112K	Buy	+10,894	New	+$192K	0.24%	53
2022 Q3	–	Sell	-5,103	Closed	-$262K	–	57
2022 Q2	$262K	Buy	+5,103	New	+$264K	0.61%	40
2022 Q1	–	Sell	-2,416	Closed	-$346K	–	51
2021 Q4	$346K	Buy	2,416 +408	+20%	+$70.1K	0.68%	41
2021 Q3	$416K	Buy	2,008 +31	+2%	+$6.83K	1.05%	20
2021 Q2	$420K	Buy	1,977 +233	+13%	+$42.7K	1.09%	17
2021 Q1	$316K	Buy	+1,744	New	+$348K	1.16%	22

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SevenOneSeven Capital Management's NVAX Position: Q1 2023 in Review

SevenOneSeven Capital Management sold out of Novavax (NVAX) in Q1 2023, closing a stake of 10,894 shares — an estimated $112K sold.

SevenOneSeven Capital Management first reported a position in NVAX in Q1 2021 and held it in 6 quarters. The position peaked at $420K in Q2 2021. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

SevenOneSeven Capital Management reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
SevenOneSeven Capital Management sold 10,894 Novavax shares in Q1 2023, an estimated $112K.
SevenOneSeven Capital Management first reported a position in Novavax in Q1 2021 and held it in 6 quarters.
SevenOneSeven Capital Management's Novavax position peaked at $420K in Q2 2021.
222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on SevenOneSeven Capital Management's 13F filing for Q1 2023, filed 15 May 2023.